Enas Al Ani (Enas Al-Ani)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Staphylococcus Aureus

Cross Sectional

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Dharanga Ratnayake, Michael Ansah, Enas Al Ani, Wayne Heaselgrave
The Activity of PHMB and Other Guanidino Containing Compounds against Acanthamoeba and Other Ocular Pathogens. Microorganisms 10 (7) (2022)
Enas Al Ani, Wayne Heaselgrave
The Investigation of Thymol Formulations Containing Poloxamer 407 and Hydroxypropyl Methylcellulose to Inhibit Candida Biofilm Formation and Demonstrate Improved Bio-Compatibility. Pharmaceuticals (Basel, Switzerland) 15 (1) (2022)
Enas Al Ani, David Hill, Khalid Doudin
Chlorhexidine Mucoadhesive Buccal Tablets: The Impact of Formulation Design on Drug Delivery and Release Kinetics Using Conventional and Novel Dissolution Methods. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)